Company Overview

Company name: Syqe Medical
Description: Developer of pocket-sized metered-dose cannabis inhaler designed to allow patients to reach the optimum balance between symptom relief and psycho-activities. The company’s cannabis inhaler transforms psychoactive botanical into mainstream medical drugs and utilizes selective 100-microgram dosing precision, real-time thermal and flow controllers, lung interfacing and inhalation-based drug delivery platform, enabling patients to recover diseases and regaining their quality of life.
Year founded: 2011
Parent company:
Industry: Healthcare | Group: Healthcare Devices and Supplies | Code:
Employees: 10
City: Tel Aviv
Country: Israel
Region: Middle East

Financial Highlights

Start up capital raised (USD Million): 72.53
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company received $40 million of development capital from Shavit Capital Fund in 2018.
Number of active investors:
Profile last updated: 20-Nov-2018
Last known valuation:
Last known valuation date: